Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading
Loading
Home
News
Ready-made stem cell therapies for pets could be coming

From TechCrunch

By Connie Loizos

July 4, 2025

Ready-made stem cell therapies for pets could be coming

What makes Gallant's approach different is that its therapy is allogeneic, meaning it leverages uterine-derived mesenchymal stem cells from a single donor animal of the same species, enabling the production of up to 30 million doses and making it far more scalable than earlier alternatives.

Most Recent

Dimension Capital’s $800M third fund shows the intersection of science and compute is booming

Dimension Capital’s $800M third fund shows the intersection of science and compute is booming

The four-year-old firm's latest fund is 60% larger than its second vehicle announced 18 months ago.

Jul 21, 2026

Bluecore Energy raises $10M to build portable nuclear reactors on barges

Bluecore Energy raises $10M to build portable nuclear reactors on barges

Maritime nuclear energy startup Bluecore Energy has raised $10 million in a pre-seed funding round led by Slauson & Co.

Jul 21, 2026

Colossal Biosciences reportedly in talks to raise new capital at $20B–$30B valuation

Colossal Biosciences reportedly in talks to raise new capital at $20B–$30B valuation

The de-extinction startup is looking to double or triple its previous valuation, according to the report.

Jul 20, 2026

Natural raises $30M to reinvent payments for AI agents — and take on Stripe

Natural raises $30M to reinvent payments for AI agents — and take on Stripe

The one-year-old startup aims to reinvent financial architecture for autonomous AI transactions.

Jul 20, 2026

Similar Posts

Ready-made stem cell therapies for pets could be coming

Ready-made stem cell therapies for pets could be coming

What makes Gallant's approach different is that its therapy is allogeneic, meaning it leverages uterine-derived mesenchymal stem cells from a single donor animal of the same species, enabling the production of up to 30 million doses and making it far more scalable than earlier alternatives.

Jul 4, 2025

Omeat emerges from stealth with beefy tech approach to cultivated meat growth media

Omeat emerges from stealth with beefy tech approach to cultivated meat growth media

Omeat's process uses regenerative factors extracted humanely from cow plasma to make growth media to create beef, pork, chicken or fish.

Jun 22, 2023

This startup's super metals could soon be in military drones, luxury watches, and chef's knives

This startup's super metals could soon be in military drones, luxury watches, and chef's knives

Foundation Alloy raised a $22 million Series A led by Voyager Ventures with participation from Trust Ventures, Yamaha Motor Ventures, America's Frontier Fund, Overlap Holdings, Material Impact, Engine Ventures, El Cap, and Kanematsu Corporation to scale its solid-state metals manufacturing.

Jun 16, 2026

Cortical Labs raises $10M for its Pong-playing stem cells which eventually could power AI

Cortical Labs raises $10M for its Pong-playing stem cells which eventually could power AI

While Generative AI is buzzy right now, what OpenAI, Microsoft and Google are doing may be only part of the story. There is also the process of using biology: the idea of using stem cells to create biocomputers that could potentially be smarter and more energy efficient than what we are used to today. Australian […]

Apr 19, 2023

Most Recent

Dimension Capital’s $800M third fund shows the intersection of science and compute is booming

Dimension Capital’s $800M third fund shows the intersection of science and compute is booming

The four-year-old firm's latest fund is 60% larger than its second vehicle announced 18 months ago.

Jul 21, 2026

Bluecore Energy raises $10M to build portable nuclear reactors on barges

Bluecore Energy raises $10M to build portable nuclear reactors on barges

Maritime nuclear energy startup Bluecore Energy has raised $10 million in a pre-seed funding round led by Slauson & Co.

Jul 21, 2026

Colossal Biosciences reportedly in talks to raise new capital at $20B–$30B valuation

Colossal Biosciences reportedly in talks to raise new capital at $20B–$30B valuation

The de-extinction startup is looking to double or triple its previous valuation, according to the report.

Jul 20, 2026

Natural raises $30M to reinvent payments for AI agents — and take on Stripe

Natural raises $30M to reinvent payments for AI agents — and take on Stripe

The one-year-old startup aims to reinvent financial architecture for autonomous AI transactions.

Jul 20, 2026

Similar Posts

Ready-made stem cell therapies for pets could be coming

Ready-made stem cell therapies for pets could be coming

What makes Gallant's approach different is that its therapy is allogeneic, meaning it leverages uterine-derived mesenchymal stem cells from a single donor animal of the same species, enabling the production of up to 30 million doses and making it far more scalable than earlier alternatives.

Jul 4, 2025

Omeat emerges from stealth with beefy tech approach to cultivated meat growth media

Omeat emerges from stealth with beefy tech approach to cultivated meat growth media

Omeat's process uses regenerative factors extracted humanely from cow plasma to make growth media to create beef, pork, chicken or fish.

Jun 22, 2023

This startup's super metals could soon be in military drones, luxury watches, and chef's knives

This startup's super metals could soon be in military drones, luxury watches, and chef's knives

Foundation Alloy raised a $22 million Series A led by Voyager Ventures with participation from Trust Ventures, Yamaha Motor Ventures, America's Frontier Fund, Overlap Holdings, Material Impact, Engine Ventures, El Cap, and Kanematsu Corporation to scale its solid-state metals manufacturing.

Jun 16, 2026

Cortical Labs raises $10M for its Pong-playing stem cells which eventually could power AI

Cortical Labs raises $10M for its Pong-playing stem cells which eventually could power AI

While Generative AI is buzzy right now, what OpenAI, Microsoft and Google are doing may be only part of the story. There is also the process of using biology: the idea of using stem cells to create biocomputers that could potentially be smarter and more energy efficient than what we are used to today. Australian […]

Apr 19, 2023